相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bariatric Surgery in Adolescents with Obesity: Long-Term Perspectives and Potential Alternatives
Rana Halloun et al.
HORMONE RESEARCH IN PAEDIATRICS (2022)
Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
Christine G. Lee et al.
DIABETES CARE (2021)
Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity
Mojca Jensterle et al.
Hormone Research in Paediatrics (2021)
Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?
Young Jin Tak et al.
CURRENT OBESITY REPORTS (2021)
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial
Thomas A. Wadden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial
Melanie Davies et al.
LANCET (2021)
Once-Weekly Semaglutide in Adults with Overweight or Obesity
John P. H. Wilding et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Metformin Treatment of Pediatric Obesity
Vandana Raman et al.
PEDIATRICS (2021)
Efficacy and Safety of Metformin for Obesity: A Systematic Review
Reem Masarwa et al.
PEDIATRICS (2021)
COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity
Eun Sil Kim et al.
SCIENTIFIC REPORTS (2021)
Weight Gain Associated with COVID-19 Lockdown in Children and Adolescents: A Systematic Review and Meta-Analysis
Tu-Hsuan Chang et al.
NUTRIENTS (2021)
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial
Domenica Rubino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis
Paul M. Ryan et al.
JOURNAL OF PEDIATRICS (2021)
The Impact of Obesity on Disease Severity and Outcomes Among Hospitalized Children With COVID-19
Sandeep Tripathi et al.
Hospital pediatrics (2021)
Changes in Body Mass Index Among Children and Adolescents During the COVID-19 Pandemic
Susan J. Woolford et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alstrom syndrome: Phase 3 trial design
Robert M. Haws et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2021)
GDF15 mediates the effects of metformin on body weight and energy balance
Anthony P. Coll et al.
NATURE (2020)
A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity
D. Weghuber et al.
PEDIATRIC OBESITY (2020)
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
Aaron S. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
Robert F. Kushner et al.
OBESITY (2020)
Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome
Robert Haws et al.
DIABETES OBESITY & METABOLISM (2020)
Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity
Jiska Van Schaik et al.
OBESITY FACTS (2020)
Cancer Risk Associated with Lorcaserin - The FDA's Review of the CAMELLIA-TIMI 61 Trial
John Sharretts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
Karine Clement et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Cardiovascular Safety During and After Use of Phentermine and Topiramate
Mary E. Ritchey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study
John W. Apolzan et al.
ANNALS OF INTERNAL MEDICINE (2019)
Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor Activation
Shubh Sharma et al.
MOLECULES (2019)
Metabolic and Bariatric Surgery for Pediatric Patients With Severe Obesity
Christopher F. Bolling et al.
PEDIATRICS (2019)
Pediatric Metabolic and Bariatric Surgery: Evidence, Barriers, and Best Practices
Sarah C. Armstrong et al.
PEDIATRICS (2019)
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Daniel J. Drucker
CELL METABOLISM (2018)
A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials
Vanita R. Aroda
DIABETES OBESITY & METABOLISM (2018)
ASMBS pediatric metabolic and bariatric surgery guidelines, 2018
Janey S. A. Pratt et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2018)
The Potential Role of Combination Pharmacotherapy to Improve Outcomes of Pediatric Obesity: A Case Report and Discussion
Claudia K. Fox et al.
FRONTIERS IN PEDIATRICS (2018)
Effect of phentermine on weight reduction in a pediatric weight management clinic
J. R. Ryder et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment
Thomas C. Marbury et al.
CLINICAL PHARMACOKINETICS (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome
P. Salehi et al.
PEDIATRIC OBESITY (2017)
BMI changes in adolescents treated with bupropion SR for smoking cessation
Lysbeth Floden et al.
OBESITY (2016)
Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review
Igho J. Onakpoya et al.
BMC MEDICINE (2016)
The cilium: a cellular antenna with an influence on obesity risk
Edwin C. M. Mariman et al.
BRITISH JOURNAL OF NUTRITION (2016)
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
Jean L. Chan et al.
CLINICAL ENDOCRINOLOGY (2016)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY
W. Timothy Garvey et al.
ENDOCRINE PRACTICE (2016)
A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity
Jefferson P. Lomenick et al.
OBESITY (2016)
Meal Replacements Followed by Topiramate for the Treatment of Adolescent Severe Obesity: A Pilot Randomized Controlled Trial
Claudia K. Fox et al.
OBESITY (2016)
The BBSome Controls Energy Homeostasis by Mediating the Transport of the Leptin Receptor to the Plasma Membrane
Deng-Fu Guo et al.
PLOS GENETICS (2016)
Stimulants for the Control of Hedonic Appetite
Alison S. Poulton et al.
Frontiers in Pharmacology (2016)
Naltrexone Extended-Release Plus Bupropion Extended-Release for Treatment of Obesity
Susan Z. Yanovski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Caroline M Apovian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Topiramate for Weight Reduction in Adolescents With Severe Obesity
Claudia K. Fox et al.
CLINICAL PEDIATRICS (2015)
Liraglutide as a Potentially Useful Agent for Regulating Appetite in Diabetic Patients with Hypothalamic Hyperphagia and Obesity
Takao Ando et al.
INTERNAL MEDICINE (2014)
Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food cues
G-J Wang et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells
Young-Sun Lee et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Effects of metformin on weight loss: potential mechanisms
Steven K. Malin et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2014)
New pharmacological perspectives for the leptin receptor in the treatment of obesity
Clara Roujeau et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Severe Obesity in Children and Adolescents: Identification, Associated Health Risks, and Treatment Approaches A Scientific Statement From the American Heart Association
Aaron S. Kelly et al.
CIRCULATION (2013)
A truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice
Deborah Heydet et al.
DEVELOPMENTAL NEUROBIOLOGY (2013)
Chronic Treatment With a Melanocortin-4 Receptor Agonist Causes Weight Loss, Reduces Insulin Resistance, and Improves Cardiovascular Function in Diet-Induced Obese Rhesus Macaques
Paul Kievit et al.
DIABETES (2013)
Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
Priscilla Hollander et al.
DIABETES CARE (2013)
GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases
Flavius Zoicas et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II)
Caroline M. Apovian et al.
OBESITY (2013)
The Effect of Glucagon-Like Peptide-1 Receptor Agonist Therapy on Body Mass Index in Adolescents With Severe Obesity A Randomized, Placebo-Controlled, Clinical Trial
Aaron S. Kelly et al.
JAMA PEDIATRICS (2013)
Response of Severely Obese Children and Adolescents to Behavioral Treatment
Pernilla Danielsson et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2012)
Exenatide as a Weight-Loss Therapy in Extreme Pediatric Obesity: A Randomized, Controlled Pilot Study
Aaron S. Kelly et al.
OBESITY (2012)
Safety, tolerability, and efficacy of metformin extended-release oral antidiabetic therapy in patients with type 2 diabetes: An observational trial in Asia
Chul-Hee Kim et al.
JOURNAL OF DIABETES (2012)
Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing
Mark Fineman et al.
CLINICAL PHARMACOKINETICS (2011)
CLINICAL EFFECTS OF LONG-TERM METRELEPTIN TREATMENT IN PATIENTS WITH LIPODYSTROPHY
Jean L. Chan et al.
ENDOCRINE PRACTICE (2011)
Genetic approaches to understanding human obesity
Shwetha Ramachandrappa et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus
Chrysi Koliaki et al.
Diabetes Therapy (2011)
Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy
Jill K. Hamilton et al.
INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY (2011)
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Frank L. Greenway et al.
LANCET (2010)
Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus
Juliana Levy et al.
DIABETOLOGY & METABOLIC SYNDROME (2010)
Modulation of Blood Pressure by Central Melanocortinergic Pathways
Jerry R. Greenfield et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Rational Design of a Combination Medication for the Treatment of Obesity
Frank L. Greenway et al.
OBESITY (2009)
Meta-analysis: Pharmacologic treatment of obesity
ZP Li et al.
ANNALS OF INTERNAL MEDICINE (2005)
Gastrointestinal tolerability of extended-release metformin tablets compared to immediaterelease metformin tablets: results of a retrospective cohort study
L Blonde et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Orlistat, a new lipase inhibitor for the management of obesity
AM Heck et al.
PHARMACOTHERAPY (2000)
分享论文
